title: Endovascular treatment of residual type A aortic dissection preserving patency of supra-aortic vessels by implantation of the Djumbodis® system. No more surgery for the aortic arch?
abstract: A persistent distal false lumen perfusion--residual type A aortic dissection--is found in 50% to 100% of patients following ascending aorta replacement. Complications of persistent or newly developed dissection of the distal aorta are often fatal and require reoperation, leading to a higher morbidity and mortality rate for these patients than with primary surgery. Thus, many efforts have been done to treat this aortic disease by an endovascular approach. Unfortunately, patency of the supra-aortic vessel still remains an unresolved issue. The present report describes the case of a patient with a residual type A aortic dissection persisting after ascending aorta replacement, successfully treated by implantation of a new endovascular device, the Djumbodis® Dissection System, a bare stent with sufficiently large mesh to join the dissected layers without occluding main vital branches such as supra-aortic arteries.
authors: University of Naples Federico II, Department of Internal Medicine, Cardiovascular and Immunulogical Sciences, via Sergio Pansini 5 Naples, 80131, Italy. pcirillo@unina.it
authors: Plinio
authors: P
authors: Cirillo
authors: Gabriele
authors: G
authors: Iannelli
authors: Federico
authors: F
authors: Piscione
mesh_terms: D000368:Aged; D001011:Aorta / Q000502:physiology*; D001013:Aorta, Thoracic / Q000502:physiology / Q000601:surgery*; D001019:Aortic Rupture / Q000628:therapy*; D002404:Catheterization / Q000295:instrumentation*; D057510:Endovascular Procedures / Q000295:instrumentation / Q000379:methods*; D006470:Hemorrhage / Q000453:epidemiology; D006801:Humans; D008297:Male; D012307:Risk Factors; D015607:Stents; D016896:Treatment Outcome; D058017:Vascular Grafting / Q000009:adverse effects; D014654:Vascular Patency / Q000502:physiology*